Data science provides a foundation for an important front in the battle against COVID-19. The Harvard Data Science Review, a journal of the Harvard Data Science Initiative, is helping keep data scientists connected and up to date on the latest findings.

A public campaign to build trust may be needed if a successful vaccine candidate is to be taken by enough Americans to interrupt the COVID pandemic, a Harvard public health expert said.

To document the effects of COVID-19 on Black Americans, two colleagues and friends created an open-source library guide to serve as a repository of material and a platform to start a dialogue.

A team of undergrads is using computational biology to create a therapeutic that enables the body to quickly develop COVID-19 antibodies and jump-start the immune system’s battle against the disease.

BIDMC-led research team reports vaccine protection against severe COVID-19-related pneumonia and death.

Study findings support use of county-level cell phone location data as tool to estimate future trends of the COVID-19 pandemic.

How COVID-19 is evaporating our casual connections and taking an important source of happiness.

Mass General study shows the benefits of inhaled nitric oxide therapy for pregnant patients with severe and critical COVID-19.

Harvard University and AbbVie have announced a $30 million collaborative research alliance to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever.

A new study has found that children infected with the virus that causes COVID-19 were shown to have a significantly higher level of virus in their airways than hospitalized adults in ICUs for COVID-19 treatment.